Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1983-01-19
1984-04-10
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260396R, 424304, A61K 3112, A61K 31275, C07C 5000, C07C 9718
Patent
active
044421273
ABSTRACT:
Psoriasis in mammals is relieved by topically administering naphthoquinones of the formula: ##STR1## wherein: R.sup.1 and R.sup.2 are lower alkoxy; and
REFERENCES:
patent: 3914264 (1975-10-01), Marsico et al.
patent: 4229478 (1980-10-01), Jones et al.
Chemical Abstracts 38:3278 (1944).
Chemical Abstracts 42:7750 (1978).
Chemical Abstracts 52:12011b (1958).
Jones Gordon H.
Young John M.
Moore Annette M.
Moran Tom M.
Schenkman Leonard
Syntex (U.S.A.) Inc.
LandOfFree
Naphthoquinone anti-psoriatic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphthoquinone anti-psoriatic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthoquinone anti-psoriatic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-892693